The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 30, 2014

Filed:

Dec. 14, 2010
Applicants:

Arnd Steuernagel, Goettingen, DE;

Erik Fiedler, Halle/Saale, DE;

Markus Fiedler, Halle/Saale, DE;

Anja Kunert, Halle/Saale, DE;

Joerg Nerkamp, Halle/Saale, DE;

Thomas Goettler, Halle/Saale, DE;

Manja Gloser, Teutschenthal, DE;

Ilka Haenssgen, Halle/Saale, DE;

Inventors:

Arnd Steuernagel, Goettingen, DE;

Erik Fiedler, Halle/Saale, DE;

Markus Fiedler, Halle/Saale, DE;

Anja Kunert, Halle/Saale, DE;

Joerg Nerkamp, Halle/Saale, DE;

Thomas Goettler, Halle/Saale, DE;

Manja Gloser, Teutschenthal, DE;

Ilka Haenssgen, Halle/Saale, DE;

Assignee:

Scil Proteins GmbH, Halle/Saale, unknown;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/00 (2006.01); C12N 15/10 (2006.01); C07K 14/47 (2006.01); C07K 14/435 (2006.01); C07K 14/525 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1034 (2013.01); C12N 15/1041 (2013.01); G01N 33/6878 (2013.01); C12N 15/1044 (2013.01); C07K 14/47 (2013.01); G01N 33/6845 (2013.01); C12N 15/1037 (2013.01); C07K 14/435 (2013.01); C07K 2319/95 (2013.01); C07K 14/525 (2013.01); C07K 2319/31 (2013.01);
Abstract

The present invention refers to novel hetero-multimeric proteins obtained from modified ubiquitin capable of binding the extradomain B of fibronectin (ED-B) with high affinity. Furthermore, the invention refers to fusion proteins comprising said recombinant protein fused to a pharmaceutically and/or diagnostically active component. The invention is further directed to the use of said proteins in medical treatment methods.


Find Patent Forward Citations

Loading…